Angiodynamics (ANGO) Raw Materials (2012 - 2014)

Angiodynamics (ANGO) has reported Raw Materials for 3 consecutive years, with $23.3 million the latest figure, recorded in Q1 2014.

• For the quarter ending Q1 2014, Raw Materials changed N/A year-over-year to $23.3 million; the trailing twelve-month figure through Feb 2014 stood at $23.3 million (changed N/A YoY), and the FY2013 full-year result was $18.4 million, down 3.28% from the prior year.
• Raw Materials slipped to $23.3 million in Q1 2014 per ANGO's latest filing, from $24.3 million in the prior quarter.
• Across five years, Raw Materials topped out at $24.3 million in Q4 2013 and bottomed at $18.4 million in Q2 2013.
• Historically, Raw Materials has averaged $21.2 million across 3 years, with a median of $21.0 million in 2012.
• The widest YoY moves for Raw Materials: up 7.67% in 2013, down 3.28% in 2013.
• Over 3 years, Raw Materials stood at $20.2 million in 2012, then grew by 20.17% to $24.3 million in 2013, then retreated by 3.99% to $23.3 million in 2014.
• According to Business Quant data, Raw Materials over the past three periods registered $23.3 million, $24.3 million, and $21.8 million for Q1 2014, Q4 2013, and Q3 2013 respectively.